Works matching IS 17597706 AND DT 2023 AND VI 14 AND IP 17

Results: 14

Is response evaluation criteria in solid tumors (RECIST) effective in patient selection for radical resection after neoadjuvant immunotherapy with advanced NSCLC?

Published in:

Thoracic Cancer, 2023, v. 14, n. 17, p. 1635, doi. 10.1111/1759-7714.14909

By:

Xu, Yuan;
Ma, Dongjie;
Qin, Yingzhi;
Li, Shanqing;
Li, Ji;
Jiang, Ying;
Wang, Mengzhao;
Xu, Yan;
Zhao, Jing;
Chen, Minjiang;
Cheng, Wuying;
Hu, Ke;
Liu, Hongsheng

Publication type:

Article

Surgical treatment for lung metastasis of inflammatory myofibroblastic tumor of the lung: A case report.

Published in:

Thoracic Cancer, 2023, v. 14, n. 17, p. 1644, doi. 10.1111/1759-7714.14914

By:

Iwai, Hidenobu;
Yanagawa, Naoki;
Deguchi, Hiroyuki;
Tomoyasu, Makoto;
Shigeeda, Wataru;
Kaneko, Yuka;
Yoshimura, Ryuichi;
Kanno, Hironaga;
Sugai, Mayu;
Shikanai, Shunsuke;
Sugai, Tamotsu;
Saito, Hajime

Publication type:

Article

Successful resection after first‐line lenvatinib therapy in an advanced thymic carcinoma.

Published in:

Thoracic Cancer, 2023, v. 14, n. 17, p. 1640, doi. 10.1111/1759-7714.14913

By:

Shimura, Masatoshi;
Miura, Kentaro;
Koizumi, Tomonobu;
Kanda, Shintaro;
Mishima, Shuji;
Hara, Daisuke;
Matsuoka, Shunichiro;
Eguchi, Takashi;
Hamanaka, Kazutoshi;
Uehara, Takeshi;
Shimizu, Kimihiro

Publication type:

Article

GTSE1 promotes the growth of NSCLC by regulating microtubule‐associated proteins through the ERK/MAPK pathway.

Published in:

Thoracic Cancer, 2023, v. 14, n. 17, p. 1624, doi. 10.1111/1759-7714.14908

By:

Wang, Chuanlin;
Wen, Meiyan;
Xu, Jiali;
Gao, Pengning;
Liu, Shanling;
Liu, Jiayu;
Chen, Ying;
Zhou, Lan

Publication type:

Article

Efficacy of immune checkpoint inhibitor therapy in patients with pulmonary sarcomatoid carcinoma in clinical practice.

Published in:

Thoracic Cancer, 2023, v. 14, n. 17, p. 1618, doi. 10.1111/1759-7714.14907

By:

Inomata, Minehiko;
Tsuda, Takeshi;
Ichikawa, Tomomi;
Matsumoto, Masahiro;
Mizushima, Isami;
Azechi, Kenji;
Takata, Naoki;
Murayama, Nozomu;
Hayashi, Kana;
Hirai, Takahiro;
Seto, Zenta;
Tokui, Kotaro;
Masaki, Yasuaki;
Taka, Chihiro;
Okazawa, Seisuke;
Kambara, Kenta;
Imanishi, Shingo;
Taniguchi, Hirokazu;
Miwa, Toshiro;
Hayashi, Ryuji

Publication type:

Article

Propofol mediates non‐small cell lung cancer growth in part by regulating circ_0003028‐related mechanisms.

Published in:

Thoracic Cancer, 2023, v. 14, n. 17, p. 1606, doi. 10.1111/1759-7714.14906

By:

Zhang, Xiuli;
Liu, Dongzhi;
Wang, Ping;
Liu, Naihe

Publication type:

Article

Clinical benefit of platinum doublet combination therapy in older adults with advanced non‐small cell lung cancer: A prospective multicenter study by the National Hospital Organization in Japan.

Published in:

Thoracic Cancer, 2023, v. 14, n. 17, p. 1597, doi. 10.1111/1759-7714.14904

By:

Shimokawa, Mototsugu;
Kanazu, Masaki;
Saito, Ryusei;
Mori, Masahide;
Tamura, Atsuhisa;
Okano, Yoshio;
Fujita, Yuka;
Endo, Takeo;
Motegi, Mitsuru;
Takata, Shohei;
Kita, Toshiyuki;
Sukoh, Noriaki;
Mizuki, Fumitaka;
Takenoyama, Mitsuhiro;
Atagi, Shinji

Publication type:

Article

Correlations between pathogenic variants in DNA repair genes and anticancer treatment efficacy in stage IV non‐small cell lung cancer: A large real‐world cohort and review of the literature.

Published in:

Thoracic Cancer, 2023, v. 14, n. 17, p. 1589, doi. 10.1111/1759-7714.14902

By:

Averbuch, Itamar;
Tschernichovsky, Roi;
Icht, Oded;
Goldstein, Daniel A.;
Mutai, Raz;
Dudnik, Elizabeth;
Rotem, Ofer;
Peled, Nir;
Allen, Aaron M.;
Laufer‐Geva, Smadar;
Goldberg, Yael;
Zer, Alona

Publication type:

Article

RNF128 expression in lung adenocarcinoma is a favorable prognostic factor associated with decreased tumor‐associated macrophages.

Published in:

Thoracic Cancer, 2023, v. 14, n. 17, p. 1581, doi. 10.1111/1759-7714.14901

By:

Fujimoto, Syuusuke;
Kyuichi, Kadota;
Kaede, Yamada;
Chihiro, Yoshida;
Emi, Ibuki;
Ryo, Ishikawa;
Reiji, Haba;
Toshiki, Yajima;
Yokomise, Hiroyasu

Publication type:

Article

Survival and medical costs of non‐small cell lung cancer patients according to the first‐line treatment: An observational study using the Kyoto City Integrated Database.

Published in:

Thoracic Cancer, 2023, v. 14, n. 17, p. 1574, doi. 10.1111/1759-7714.14900

By:

Shimamoto, Tomonari;
Tateyama, Yukiko;
Kobayashi, Daisuke;
Yamamoto, Keiichi;
Takahashi, Yoshimitsu;
Ueshima, Hiroaki;
Sasaki, Kosuke;
Nakayama, Takeo;
Iwami, Taku

Publication type:

Article

The effects of inspiratory muscle training with pulmonary rehabilitation on NSCLC patients during radiation therapy: A pilot clinical study.

Published in:

Thoracic Cancer, 2023, v. 14, n. 17, p. 1567, doi. 10.1111/1759-7714.14899

By:

Do, Junghwa;
Lee, Seung Hak;
Kim, Sang Ah;
Kim, A Hyun;
Gelvosa, Ma. Nessa;
Cheon, Hwayeong;
Jeon, Jae Yong

Publication type:

Article

Pretreatment absolute lymphocyte count is an independent predictor for survival outcomes for esophageal squamous cell carcinoma patients treated with neoadjuvant chemoradiotherapy and pembrolizumab: An analysis from a prospective cohort.

Published in:

Thoracic Cancer, 2023, v. 14, n. 17, p. 1556, doi. 10.1111/1759-7714.14898

By:

Qi, Wei‐Xiang;
Wang, Xiaoyan;
Li, Chengqiang;
Li, Shuyan;
Li, Huan;
Xu, Feifei;
Chen, Jiayi;
Zhao, Shengguang;
Li, Hecheng

Publication type:

Article

Downregulation of circ_PLXND1 inhibits tumorigenesis of non‐small cell lung carcinoma via miR‐1287‐5p/ERBB3 axis.

Published in:

Thoracic Cancer, 2023, v. 14, n. 17, p. 1543, doi. 10.1111/1759-7714.14897

By:

Wu, Jinzhou;
Liu, Chenyang;
Yu, Guiping

Publication type:

Article

Issue Information.

Published in:: Thoracic Cancer, 2023, v. 14, n. 17, p. 1541, doi. 10.1111/1759-7714.14503
Publication type:: Article